David Howard Walker, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 State St, Medford, OR 97504 Phone: 541-779-1672 Fax: 541-779-0986 |
Thomas Purtzer, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1322 E Mcandrews Rd, Ste 101, Medford, OR 97504 Phone: 541-770-1650 |
Donald Andrew Ross, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 State St, Medford, OR 97504 Phone: 541-779-1672 Fax: 541-618-9434 |
Timothy David Uschold, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 State St, Medford, OR 97504 Phone: 541-779-1672 Fax: 541-779-0986 |
Jeffrey Allen Louie, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2900 State St, Medford, OR 97504 Phone: 541-779-1672 Fax: 541-818-9434 |
Brooke Nicole Buckland, PA-C Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2900 State St, Medford, OR 97504 Phone: 541-779-1672 |
Miroslav Patrick Bobek, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 State St, Medford, OR 97504 Phone: 541-779-1672 Fax: 541-779-0986 |
News Archive
Princeton chemists have found a way to make a naturally occurring enzyme take on a new, artificial role, which has significant implications for modern chemistry, including pharmaceutical production.
IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
A discovery made by investigators from Beth Israel Deaconess Medical Center and the Boston University School of Medicine may help lead to the development of a cell-based regenerative therapy which could be used to restore thyroid function in patients with cancer who have had their thyroids surgically removed and children born with congenital hypothyroidism.
A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current medical advice to continue using these drugs as indicated irrespective of the ongoing pandemic but indicates the need for more research to rule out any additional risk of severe illness due to these agents.
Several of the city's most troubled hospitals are partially or completely uninsured for malpractice, state records show, forgoing what is considered a standard safeguard across the country.
› Verified 6 days ago